Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach
Descripción del Articulo
Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was t...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2019 |
| Institución: | Consejo Nacional de Ciencia Tecnología e Innovación |
| Repositorio: | CONCYTEC-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorio.concytec.gob.pe:20.500.12390/2661 |
| Enlace del recurso: | https://hdl.handle.net/20.500.12390/2661 https://doi.org/10.3389/fonc.2019.01429 |
| Nivel de acceso: | acceso abierto |
| Materia: | massively parallel sequencing breast cancer susceptibility germline pathogenic variants HBOC Latin America http://purl.org/pe-repo/ocde/ford#3.04.03 |
| id |
CONC_6ed03fad8be9f0b1fd92864777a5190b |
|---|---|
| oai_identifier_str |
oai:repositorio.concytec.gob.pe:20.500.12390/2661 |
| network_acronym_str |
CONC |
| network_name_str |
CONCYTEC-Institucional |
| repository_id_str |
4689 |
| dc.title.none.fl_str_mv |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| title |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| spellingShingle |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach Oliver J. massively parallel sequencing breast cancer susceptibility germline pathogenic variants HBOC Latin America http://purl.org/pe-repo/ocde/ford#3.04.03 |
| title_short |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| title_full |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| title_fullStr |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| title_full_unstemmed |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| title_sort |
Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach |
| author |
Oliver J. |
| author_facet |
Oliver J. Quezada Urban R. Franco Cortés C.A. Díaz Velásquez C.E. Montealegre Paez A.L. Pacheco-Orozco R.A. Castro Rojas C. García-Robles R. López Rivera J.J. Gaitán Chaparro S. Gómez A.M. Suarez Obando F. Giraldo G. Maya M.I. Hurtado-Villa P. Sanchez A.I. Serrano N. Orduz Galvis A.I. Aruachan S. Nuñez Castillo J. Frecha C. Riggi C. Jauk F. Gómez García E.M. Carranza C.L. Zamora V. Torres Mejía G. Romieu I. Castañeda C.A. Castillo M. Gitler R. Antoniano A. Rojas Jiménez E. Romero Cruz L.E. Vallejo Lecuona F. Delgado Enciso I. Martínez Rizo A.B. Flores Carranza A. Benites Godinez V. Méndez Catalá C.F. Herrera L.A. Chirino Y.I. Terrazas L.I. Perdomo S. Vaca Paniagua F. LACAM Study |
| author_role |
author |
| author2 |
Quezada Urban R. Franco Cortés C.A. Díaz Velásquez C.E. Montealegre Paez A.L. Pacheco-Orozco R.A. Castro Rojas C. García-Robles R. López Rivera J.J. Gaitán Chaparro S. Gómez A.M. Suarez Obando F. Giraldo G. Maya M.I. Hurtado-Villa P. Sanchez A.I. Serrano N. Orduz Galvis A.I. Aruachan S. Nuñez Castillo J. Frecha C. Riggi C. Jauk F. Gómez García E.M. Carranza C.L. Zamora V. Torres Mejía G. Romieu I. Castañeda C.A. Castillo M. Gitler R. Antoniano A. Rojas Jiménez E. Romero Cruz L.E. Vallejo Lecuona F. Delgado Enciso I. Martínez Rizo A.B. Flores Carranza A. Benites Godinez V. Méndez Catalá C.F. Herrera L.A. Chirino Y.I. Terrazas L.I. Perdomo S. Vaca Paniagua F. LACAM Study |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Oliver J. Quezada Urban R. Franco Cortés C.A. Díaz Velásquez C.E. Montealegre Paez A.L. Pacheco-Orozco R.A. Castro Rojas C. García-Robles R. López Rivera J.J. Gaitán Chaparro S. Gómez A.M. Suarez Obando F. Giraldo G. Maya M.I. Hurtado-Villa P. Sanchez A.I. Serrano N. Orduz Galvis A.I. Aruachan S. Nuñez Castillo J. Frecha C. Riggi C. Jauk F. Gómez García E.M. Carranza C.L. Zamora V. Torres Mejía G. Romieu I. Castañeda C.A. Castillo M. Gitler R. Antoniano A. Rojas Jiménez E. Romero Cruz L.E. Vallejo Lecuona F. Delgado Enciso I. Martínez Rizo A.B. Flores Carranza A. Benites Godinez V. Méndez Catalá C.F. Herrera L.A. Chirino Y.I. Terrazas L.I. Perdomo S. Vaca Paniagua F. LACAM Study |
| dc.subject.none.fl_str_mv |
massively parallel sequencing |
| topic |
massively parallel sequencing breast cancer susceptibility germline pathogenic variants HBOC Latin America http://purl.org/pe-repo/ocde/ford#3.04.03 |
| dc.subject.es_PE.fl_str_mv |
breast cancer susceptibility germline pathogenic variants HBOC Latin America |
| dc.subject.ocde.none.fl_str_mv |
http://purl.org/pe-repo/ocde/ford#3.04.03 |
| description |
Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in susceptibility to different hereditary cancers. Libraries were sequenced in MiSeq (Illumina, Inc.) and PGM (Ion Torrent-Thermo Fisher Scientific) platforms. Results: The overall prevalence of pathogenic variants was 17% (38/222); the distribution spanned 14 genes and varied by country. The highest relative prevalence of pathogenic variants was found in patients from Argentina (25%, 14/57), followed by Mexico (18%, 12/68), Guatemala (16%, 3/19), and Colombia (13%, 10/78). Pathogenic variants were found in BRCA1 (20%) and BRCA2 (29%) genes. Pathogenic variants were found in other 12 genes, including high and moderate risk genes such as MSH2, MSH6, MUTYH, and PALB2. Additional pathogenic variants were found in HBOC unrelated genes such as DCLRE1C, WRN, PDE11A, and PDGFB. Conclusion: In this first phase of the project, we recruited 403 individuals and evaluated the germline genetic alterations in an initial cohort of 222 patients among 4 countries. Our data show for the first time in LA the distribution of pathogenic variants in a broad set of cancer susceptibility genes in HBOC. Even though we used extended gene panels, there was still a high proportion of patients without any detectable pathogenic variant, which emphasizes the larger, unexplored genetic nature of the disease in these populations. © Copyright © 2019 Oliver, Quezada Urban, Franco Cortés, Díaz Velásquez, Montealegre Paez, Pacheco-Orozco, Castro Rojas, García-Robles, López Rivera, Gaitán Chaparro, Gómez, Suarez Obando, Giraldo, Maya, Hurtado-Villa, Sanchez, Serrano, Orduz Galvis, Aruachan, Nuñez Castillo, Frecha, Riggi, Jauk, Gómez García, Carranza, Zamora, Torres Mejía, Romieu, Castañeda, Castillo, Gitler, Antoniano, Rojas Jiménez, Romero Cruz, Vallejo Lecuona, Delgado Enciso, Martínez Rizo, Flores Carranza, Benites Godinez, Méndez Catalá, Herrera, Chirino, Terrazas, Perdomo and Vaca Paniagua. |
| publishDate |
2019 |
| dc.date.accessioned.none.fl_str_mv |
2024-05-30T23:13:38Z |
| dc.date.available.none.fl_str_mv |
2024-05-30T23:13:38Z |
| dc.date.issued.fl_str_mv |
2019 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12390/2661 |
| dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.3389/fonc.2019.01429 |
| dc.identifier.scopus.none.fl_str_mv |
2-s2.0-85077464342 |
| url |
https://hdl.handle.net/20.500.12390/2661 https://doi.org/10.3389/fonc.2019.01429 |
| identifier_str_mv |
2-s2.0-85077464342 |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartof.none.fl_str_mv |
Frontiers in Oncology |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.publisher.none.fl_str_mv |
Frontiers Media S.A. |
| publisher.none.fl_str_mv |
Frontiers Media S.A. |
| dc.source.none.fl_str_mv |
reponame:CONCYTEC-Institucional instname:Consejo Nacional de Ciencia Tecnología e Innovación instacron:CONCYTEC |
| instname_str |
Consejo Nacional de Ciencia Tecnología e Innovación |
| instacron_str |
CONCYTEC |
| institution |
CONCYTEC |
| reponame_str |
CONCYTEC-Institucional |
| collection |
CONCYTEC-Institucional |
| bitstream.url.fl_str_mv |
https://repositorio.concytec.gob.pe/bitstreams/bfab0d3d-747f-4729-9599-4ae9d4e6b72d/download https://repositorio.concytec.gob.pe/bitstreams/2e62dbf3-ac91-43ac-aeea-83bcce923884/download https://repositorio.concytec.gob.pe/bitstreams/7dcd82a7-a55f-4810-878f-6f6c00db90c5/download |
| bitstream.checksum.fl_str_mv |
518c3310ac0f9b685b58e7ff240dcbf8 8554030a50ef7b87678d45a887d204a1 448f284f3eba36af6cb9760fce695024 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional CONCYTEC |
| repository.mail.fl_str_mv |
repositorio@concytec.gob.pe |
| _version_ |
1844883054589378560 |
| spelling |
Publicationrp07026600rp07060600rp07051600rp07020600rp07040600rp07049600rp07054600rp07035600rp07052600rp07028600rp07029600rp07044600rp07037600rp07027600rp07023600rp07063600rp07030600rp07046600rp07047600rp07064600rp07053600rp07033600rp07057600rp07045600rp07025600rp07056600rp07024600rp07043600rp07061600rp06447600rp07059600rp07058600rp07041600rp07042600rp07031600rp07032600rp07036600rp07062600rp07050600rp07048600rp07021600rp07034600rp07022600rp07055600rp07038600rp07039600Oliver J.Quezada Urban R.Franco Cortés C.A.Díaz Velásquez C.E.Montealegre Paez A.L.Pacheco-Orozco R.A.Castro Rojas C.García-Robles R.López Rivera J.J.Gaitán Chaparro S.Gómez A.M.Suarez Obando F.Giraldo G.Maya M.I.Hurtado-Villa P.Sanchez A.I.Serrano N.Orduz Galvis A.I.Aruachan S.Nuñez Castillo J.Frecha C.Riggi C.Jauk F.Gómez García E.M.Carranza C.L.Zamora V.Torres Mejía G.Romieu I.Castañeda C.A.Castillo M.Gitler R.Antoniano A.Rojas Jiménez E.Romero Cruz L.E.Vallejo Lecuona F.Delgado Enciso I.Martínez Rizo A.B.Flores Carranza A.Benites Godinez V.Méndez Catalá C.F.Herrera L.A.Chirino Y.I.Terrazas L.I.Perdomo S.Vaca Paniagua F.LACAM Study2024-05-30T23:13:38Z2024-05-30T23:13:38Z2019https://hdl.handle.net/20.500.12390/2661https://doi.org/10.3389/fonc.2019.014292-s2.0-85077464342Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in susceptibility to different hereditary cancers. Libraries were sequenced in MiSeq (Illumina, Inc.) and PGM (Ion Torrent-Thermo Fisher Scientific) platforms. Results: The overall prevalence of pathogenic variants was 17% (38/222); the distribution spanned 14 genes and varied by country. The highest relative prevalence of pathogenic variants was found in patients from Argentina (25%, 14/57), followed by Mexico (18%, 12/68), Guatemala (16%, 3/19), and Colombia (13%, 10/78). Pathogenic variants were found in BRCA1 (20%) and BRCA2 (29%) genes. Pathogenic variants were found in other 12 genes, including high and moderate risk genes such as MSH2, MSH6, MUTYH, and PALB2. Additional pathogenic variants were found in HBOC unrelated genes such as DCLRE1C, WRN, PDE11A, and PDGFB. Conclusion: In this first phase of the project, we recruited 403 individuals and evaluated the germline genetic alterations in an initial cohort of 222 patients among 4 countries. Our data show for the first time in LA the distribution of pathogenic variants in a broad set of cancer susceptibility genes in HBOC. Even though we used extended gene panels, there was still a high proportion of patients without any detectable pathogenic variant, which emphasizes the larger, unexplored genetic nature of the disease in these populations. © Copyright © 2019 Oliver, Quezada Urban, Franco Cortés, Díaz Velásquez, Montealegre Paez, Pacheco-Orozco, Castro Rojas, García-Robles, López Rivera, Gaitán Chaparro, Gómez, Suarez Obando, Giraldo, Maya, Hurtado-Villa, Sanchez, Serrano, Orduz Galvis, Aruachan, Nuñez Castillo, Frecha, Riggi, Jauk, Gómez García, Carranza, Zamora, Torres Mejía, Romieu, Castañeda, Castillo, Gitler, Antoniano, Rojas Jiménez, Romero Cruz, Vallejo Lecuona, Delgado Enciso, Martínez Rizo, Flores Carranza, Benites Godinez, Méndez Catalá, Herrera, Chirino, Terrazas, Perdomo and Vaca Paniagua.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengFrontiers Media S.A.Frontiers in Oncologyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/massively parallel sequencingbreast cancer susceptibility-1germline pathogenic variants-1HBOC-1Latin America-1http://purl.org/pe-repo/ocde/ford#3.04.03-1Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approachinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTECORIGINALLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdfLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdfapplication/pdf834065https://repositorio.concytec.gob.pe/bitstreams/bfab0d3d-747f-4729-9599-4ae9d4e6b72d/download518c3310ac0f9b685b58e7ff240dcbf8MD51TEXTLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdf.txtLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdf.txtExtracted texttext/plain67500https://repositorio.concytec.gob.pe/bitstreams/2e62dbf3-ac91-43ac-aeea-83bcce923884/download8554030a50ef7b87678d45a887d204a1MD52THUMBNAILLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdf.jpgLatin American Study of Hereditary Breast and Ovarian Cancer LACAM.pdf.jpgGenerated Thumbnailimage/jpeg5781https://repositorio.concytec.gob.pe/bitstreams/7dcd82a7-a55f-4810-878f-6f6c00db90c5/download448f284f3eba36af6cb9760fce695024MD5320.500.12390/2661oai:repositorio.concytec.gob.pe:20.500.12390/26612025-01-16 22:00:19.684https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessopen accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="0e9a29ba-dba2-49f4-b589-80fc8eca3e1b"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach</Title> <PublishedIn> <Publication> <Title>Frontiers in Oncology</Title> </Publication> </PublishedIn> <PublicationDate>2019</PublicationDate> <DOI>https://doi.org/10.3389/fonc.2019.01429</DOI> <SCP-Number>2-s2.0-85077464342</SCP-Number> <Authors> <Author> <DisplayName>Oliver J.</DisplayName> <Person id="rp07026" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Quezada Urban R.</DisplayName> <Person id="rp07060" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Franco Cortés C.A.</DisplayName> <Person id="rp07051" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Díaz Velásquez C.E.</DisplayName> <Person id="rp07020" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Montealegre Paez A.L.</DisplayName> <Person id="rp07040" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Pacheco-Orozco R.A.</DisplayName> <Person id="rp07049" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Castro Rojas C.</DisplayName> <Person id="rp07054" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>García-Robles R.</DisplayName> <Person id="rp07035" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>López Rivera J.J.</DisplayName> <Person id="rp07052" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gaitán Chaparro S.</DisplayName> <Person id="rp07028" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gómez A.M.</DisplayName> <Person id="rp07029" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Suarez Obando F.</DisplayName> <Person id="rp07044" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Giraldo G.</DisplayName> <Person id="rp07037" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Maya M.I.</DisplayName> <Person id="rp07027" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Hurtado-Villa P.</DisplayName> <Person id="rp07023" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Sanchez A.I.</DisplayName> <Person id="rp07063" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Serrano N.</DisplayName> <Person id="rp07030" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Orduz Galvis A.I.</DisplayName> <Person id="rp07046" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Aruachan S.</DisplayName> <Person id="rp07047" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Nuñez Castillo J.</DisplayName> <Person id="rp07064" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Frecha C.</DisplayName> <Person id="rp07053" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Riggi C.</DisplayName> <Person id="rp07033" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Jauk F.</DisplayName> <Person id="rp07057" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gómez García E.M.</DisplayName> <Person id="rp07045" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Carranza C.L.</DisplayName> <Person id="rp07025" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Zamora V.</DisplayName> <Person id="rp07056" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Torres Mejía G.</DisplayName> <Person id="rp07024" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Romieu I.</DisplayName> <Person id="rp07043" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Castañeda C.A.</DisplayName> <Person id="rp07061" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Castillo M.</DisplayName> <Person id="rp06447" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gitler R.</DisplayName> <Person id="rp07059" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Antoniano A.</DisplayName> <Person id="rp07058" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Rojas Jiménez E.</DisplayName> <Person id="rp07041" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Romero Cruz L.E.</DisplayName> <Person id="rp07042" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Vallejo Lecuona F.</DisplayName> <Person id="rp07031" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Delgado Enciso I.</DisplayName> <Person id="rp07032" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Martínez Rizo A.B.</DisplayName> <Person id="rp07036" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Flores Carranza A.</DisplayName> <Person id="rp07062" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Benites Godinez V.</DisplayName> <Person id="rp07050" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Méndez Catalá C.F.</DisplayName> <Person id="rp07048" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Herrera L.A.</DisplayName> <Person id="rp07021" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Chirino Y.I.</DisplayName> <Person id="rp07034" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Terrazas L.I.</DisplayName> <Person id="rp07022" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Perdomo S.</DisplayName> <Person id="rp07055" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Vaca Paniagua F.</DisplayName> <Person id="rp07038" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>LACAM Study</DisplayName> <Person id="rp07039" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Frontiers Media S.A.</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>massively parallel sequencing</Keyword> <Keyword>breast cancer susceptibility</Keyword> <Keyword>germline pathogenic variants</Keyword> <Keyword>HBOC</Keyword> <Keyword>Latin America</Keyword> <Abstract>Purpose: Hereditary Breast and Ovarian Cancer (HBOC) syndrome is responsible for ~5–10% of all diagnosed breast and ovarian cancers. Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women in Latin America (LA). The main objective of this study was to develop a comprehensive understanding of the genomic epidemiology of HBOC throughout the establishment of The Latin American consortium for HBOC-LACAM, consisting of specialists from 5 countries in LA and the description of the genomic results from the first phase of the study. Methods: We have recruited 403 individuals that fulfilled the criteria for HBOC from 11 health institutions of Argentina, Colombia, Guatemala, Mexico and Peru. A pilot cohort of 222 individuals was analyzed by NGS gene panels. One hundred forty-three genes were selected on the basis of their putative role in susceptibility to different hereditary cancers. Libraries were sequenced in MiSeq (Illumina, Inc.) and PGM (Ion Torrent-Thermo Fisher Scientific) platforms. Results: The overall prevalence of pathogenic variants was 17% (38/222); the distribution spanned 14 genes and varied by country. The highest relative prevalence of pathogenic variants was found in patients from Argentina (25%, 14/57), followed by Mexico (18%, 12/68), Guatemala (16%, 3/19), and Colombia (13%, 10/78). Pathogenic variants were found in BRCA1 (20%) and BRCA2 (29%) genes. Pathogenic variants were found in other 12 genes, including high and moderate risk genes such as MSH2, MSH6, MUTYH, and PALB2. Additional pathogenic variants were found in HBOC unrelated genes such as DCLRE1C, WRN, PDE11A, and PDGFB. Conclusion: In this first phase of the project, we recruited 403 individuals and evaluated the germline genetic alterations in an initial cohort of 222 patients among 4 countries. Our data show for the first time in LA the distribution of pathogenic variants in a broad set of cancer susceptibility genes in HBOC. Even though we used extended gene panels, there was still a high proportion of patients without any detectable pathogenic variant, which emphasizes the larger, unexplored genetic nature of the disease in these populations. © Copyright © 2019 Oliver, Quezada Urban, Franco Cortés, Díaz Velásquez, Montealegre Paez, Pacheco-Orozco, Castro Rojas, García-Robles, López Rivera, Gaitán Chaparro, Gómez, Suarez Obando, Giraldo, Maya, Hurtado-Villa, Sanchez, Serrano, Orduz Galvis, Aruachan, Nuñez Castillo, Frecha, Riggi, Jauk, Gómez García, Carranza, Zamora, Torres Mejía, Romieu, Castañeda, Castillo, Gitler, Antoniano, Rojas Jiménez, Romero Cruz, Vallejo Lecuona, Delgado Enciso, Martínez Rizo, Flores Carranza, Benites Godinez, Méndez Catalá, Herrera, Chirino, Terrazas, Perdomo and Vaca Paniagua.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1 |
| score |
13.407476 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).